{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "32973318", "DateCompleted": {"Year": "2020", "Month": "12", "Day": "18"}, "DateRevised": {"Year": "2021", "Month": "09", "Day": "24"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2020", "Month": "09", "Day": "24"}], "ELocationID": ["15699", "10.1038/s41598-020-72832-8"], "Journal": {"ISSN": "2045-2322", "JournalIssue": {"Volume": "10", "Issue": "1", "PubDate": {"Year": "2020", "Month": "Sep", "Day": "24"}}, "Title": "Scientific reports", "ISOAbbreviation": "Sci Rep"}, "ArticleTitle": "Quantification of regional murine ozone-induced lung inflammation using [<sup>18</sup>F]F-FDG microPET/CT imaging.", "Pagination": {"StartPage": "15699", "MedlinePgn": "15699"}, "Abstract": {"AbstractText": ["Ozone (O<sub>3</sub>) is a highly potent and reactive air pollutant. It has been linked to acute and chronic respiratory diseases in humans by inducing inflammation. Our studies have found evidence that 0.05\u00a0ppm of O<sub>3</sub>, within the threshold of air quality standards, is capable of inducing acute lung injury. This study was undertaken to examine O<sub>3</sub>-induced lung damage using [<sup>18</sup>F]F-FDG (2-deoxy-2-[<sup>18</sup>F]fluoro-D-glucose) microPET/CT in wild-type mice. [<sup>18</sup>F]F-FDG is a known PET tracer for inflammation. Sequential [<sup>18</sup>F]F-FDG microPET/CT was performed at baseline (i.e. before O<sub>3</sub> exposure), immediately (0\u00a0h), at 24\u00a0h and at 28\u00a0h following 2\u00a0h of 0.05\u00a0ppm O<sub>3</sub> exposure. The images were quantified to determine O<sub>3</sub> induced spatial standard uptake ratio of [<sup>18</sup>F]F-FDG in relation to lung tissue density and compared with baseline values. Immediately after O<sub>3</sub> exposure, we detected a 72.21\u2009\u00b1\u20090.79% increase in lung [<sup>18</sup>F]F-FDG uptake ratio when compared to baseline measures. At 24\u00a0h post-O<sub>3</sub> exposure, the [<sup>18</sup>F]F-FDG uptake becomes highly variable (S.D. in [<sup>18</sup>F]F-FDG\u2009=\u20095.174 \u00d7 10<sup>-4</sup> units) with a 42.54\u2009\u00b1\u20090.33% increase in lung [<sup>18</sup>F]F-FDG compared to baseline. At 28\u00a0h time-point, [<sup>18</sup>F]F-FDG uptake ratio was similar to baseline values. However, the pattern of [<sup>18</sup>F]F-FDG distribution varied and was interspersed with zones of minimal uptake. Our microPET/CT imaging protocol can quantify and identify atypical regional lung uptake of [<sup>18</sup>F]F-FDG to understand the lung response to O<sub>3</sub> exposure."]}, "AuthorList": [{"Identifier": ["0000-0002-0106-2540"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, Canada. gurpreet.aulakh@usask.ca."}], "LastName": "Aulakh", "ForeName": "G K", "Initials": "GK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, Canada."}], "LastName": "Kaur", "ForeName": "M", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, Canada."}], "LastName": "Brown", "ForeName": "V", "Initials": "V"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, Canada."}], "LastName": "Ekanayake", "ForeName": "S", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Medicine, University of Saskatchewan, Saskatoon, Canada."}], "LastName": "Khan", "ForeName": "B", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Medicine, University of Saskatchewan, Saskatoon, Canada."}, {"Identifier": [], "Affiliation": "Department of Medical Imaging, RUH Saskatoon, Saskatoon, Canada."}], "LastName": "Fonge", "ForeName": "H", "Initials": "H"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Sci Rep", "NlmUniqueID": "101563288", "ISSNLinking": "2045-2322"}, "ChemicalList": [{"RegistryNumber": "0Z5B2CJX4D", "NameOfSubstance": "Fluorodeoxyglucose F18"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Fluorodeoxyglucose F18"}, {"QualifierName": ["diagnostic imaging"], "DescriptorName": "Lung"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Ozone"}, {"QualifierName": ["diagnostic imaging", "etiology"], "DescriptorName": "Pneumonia"}, {"QualifierName": [], "DescriptorName": "Positron Emission Tomography Computed Tomography"}], "CoiStatement": "The authors declare no competing interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Aulakh GK, et al. Visualizing cellular adaptations during ozone-induced lung inflammation. FASEB J. 2019;33:767.711\u2013767.711. doi: 10.1096/fasebj.2019.33.1_supplement.767.11.", "ArticleIdList": ["10.1096/fasebj.2019.33.1_supplement.767.11"]}, {"Citation": "Brocos JA, et al. Understanding leukocyte recruitment in murine ozone-induced lung inflammation. FASEB J. 2019;33:375.310\u2013375.310. doi: 10.1096/fasebj.2019.33.1_supplement.375.10.", "ArticleIdList": ["10.1096/fasebj.2019.33.1_supplement.375.10"]}, {"Citation": "Aulakh GK, et al. Characterization of low-dose ozone-induced murine acute lung injury. Physiol. Rep. 2020;8:e14463. doi: 10.14814/phy2.14463.", "ArticleIdList": ["10.14814/phy2.14463", "PMC7287414", "32524776"]}, {"Citation": "Chen DL, et al. [18F]fluorodeoxyglucose positron emission tomography for lung antiinflammatory response evaluation. Am. J. Respir. Crit. Care Med. 2009;180:533\u2013539. doi: 10.1164/rccm.200904-0501OC.", "ArticleIdList": ["10.1164/rccm.200904-0501OC", "PMC2742744", "19574441"]}, {"Citation": "Schroeder T, et al. Modeling pulmonary kinetics of 2-deoxy-2-[18F]fluoro-d-glucose during acute lung injury. Acad. Radiol. 2008;15:763\u2013775. doi: 10.1016/j.acra.2007.12.016.", "ArticleIdList": ["10.1016/j.acra.2007.12.016", "PMC2474713", "18486012"]}, {"Citation": "Srivastava A, Mannam P. Warburg revisited: lessons for innate immunity and sepsis. Front. Physiol. 2015;6:70. doi: 10.3389/fphys.2015.00070.", "ArticleIdList": ["10.3389/fphys.2015.00070", "PMC4353299", "25806001"]}, {"Citation": "Ostroukhova M, et al. The role of low-level lactate production in airway inflammation in asthma. Am. J. Physiol. Lung Cell. Mol. Physiol. 2012;302:L300\u2013L307. doi: 10.1152/ajplung.00221.2011.", "ArticleIdList": ["10.1152/ajplung.00221.2011", "PMC3289274", "22080752"]}, {"Citation": "Rodrigues RS, et al. (18)F-fluoro-2-deoxyglucose PET informs neutrophil accumulation and activation in lipopolysaccharide-induced acute lung injury. Nucl. Med. Biol. 2017;48:52\u201362. doi: 10.1016/j.nucmedbio.2017.01.005.", "ArticleIdList": ["10.1016/j.nucmedbio.2017.01.005", "PMC5380510", "28237630"]}, {"Citation": "Harris RS, et al. 18F-FDG uptake rate is a biomarker of eosinophilic inflammation and airway response in asthma. J Nucl. Med. 2011;52:1713\u20131720. doi: 10.2967/jnumed.110.086355.", "ArticleIdList": ["10.2967/jnumed.110.086355", "PMC3855676", "21990575"]}, {"Citation": "Vanfleteren LE, et al. A possible link between increased metabolic activity of fat tissue and aortic wall inflammation in subjects with COPD. A retrospective 18F-FDG-PET/CT pilot study. Respir. Med. 2014;108:883\u2013890. doi: 10.1016/j.rmed.2014.04.001.", "ArticleIdList": ["10.1016/j.rmed.2014.04.001", "24785152"]}, {"Citation": "Chen DL, et al. Quantifying pulmonary inflammation in cystic fibrosis with positron emission tomography. Am. J. Respir. Crit. Care Med. 2006;173:1363\u20131369. doi: 10.1164/rccm.200506-934OC.", "ArticleIdList": ["10.1164/rccm.200506-934OC", "PMC2662975", "16543553"]}, {"Citation": "Hofheinz F, et al. Comparative evaluation of SUV, tumor-to-blood standard uptake ratio (SUR), and dual time point measurements for assessment of the metabolic uptake rate in FDG PET. EJNMMI Res. 2016;6:53. doi: 10.1186/s13550-016-0208-5.", "ArticleIdList": ["10.1186/s13550-016-0208-5", "PMC4917506", "27334609"]}, {"Citation": "Umeda Y, et al. Prognostic value of dual-time-point 18F-FDG PET for idiopathic pulmonary fibrosis. J. Nucl. Med. 2015;56:1869\u20131875. doi: 10.2967/jnumed.115.163360.", "ArticleIdList": ["10.2967/jnumed.115.163360", "26359263"]}, {"Citation": "Umeda Y, et al. Dual-time-point 18F-FDG PET imaging for diagnosis of disease type and disease activity in patients with idiopathic interstitial pneumonia. Eur. J. Nucl. Med. Mol. Imaging. 2009;36:1121\u20131130. doi: 10.1007/s00259-009-1069-1.", "ArticleIdList": ["10.1007/s00259-009-1069-1", "19247654"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "5", "Day": "18"}, {"Year": "2020", "Month": "9", "Day": "7"}, {"Year": "2020", "Month": "9", "Day": "25", "Hour": "5", "Minute": "58"}, {"Year": "2020", "Month": "9", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "12", "Day": "19", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "9", "Day": "24"}], "PublicationStatus": "epublish", "ArticleIdList": ["32973318", "PMC7515916", "10.1038/s41598-020-72832-8", "10.1038/s41598-020-72832-8"]}}], "PubmedBookArticle": []}